Drug Approval | December 06, 2023
Zydus receives final approval from the USFDA for Ivabradine Tablets
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
Multi-ethnic innovation helps all complexions appear clearer and more uniform
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
Currently, Venkat is Lead – Market Access, India at Pfizer
The product has been in-licensed from Strides and will be commercialized by Amneal
The company has received Form 483 with three observations
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Subscribe To Our Newsletter & Stay Updated
